Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia

Hematological Oncology

Volumn 30, Issue 3, 2012, Pages 150-155

  Özten, Nur ^b   Sunguroǧlu, Asuman ^a   Bosland, Maarten C ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

CML; GSTM1; GSTT1; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADULT; ALLELES; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; ODDS RATIO; RISK; SMOKING; TURKEY;

EID: 84866268335     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.1018     Document Type: Article

References (51)

1. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000: 75-93.
2. D'Alo F, Voso MT, Guidi F, et al. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004; 89: 664-670.
3. Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000; 111: 993-1009.
4. Loffler H, Bergmann J, Hochhaus A, et al. Reduced risk for chronic myelogenous leukemia in individuals with the cytochrome P-450 gene polymorphism CYP1A12A. Blood 2001; 98: 3874-3875.
5. Van Maele-Fabry G, Duhayon S, Lison D. A systematic review of myeloid leukemias and occupational pesticide exposure. Cancer Causes Control 2007; 18: 457-478.
6. Mehlman MA. Causal relationship from exposure to chemicals in oil refining and chemical industries and malignant melanoma. Ann N Y Acad Sci 2006; 1076: 822-828.
7. Strom SS, Yamamura Y, Kantarijian HM, Cortes-Franco JE. Obesity, weight gain, and risk of chronic myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2009; 18: 1501-1506.
8. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88.
9. Mannervik B, Board PG, Hayes JD, Listowsky I, Pearson WR. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 2005; 401: 1-8.
10. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239-1248.
11. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005; 221: 123-129.
12. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300(Pt1): 271-276.
13. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995; 4: 253-259.
14. Rojas M, Cascorbi I, Alexandrov K, et al. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis 2000; 21: 35-41.
15. Matanoski GM, Santos-Burgoa C, Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982). Environ Health Perspect 1990; 86: 107-117.
16. Mori I. Cancer mortality among man-made graphite electrode manufacturing workers: results of a 38year follow up. Occup Environ Med 2002; 59: 473-480.
17. Arruda VR, Lima CS, Grignoli CR, et al. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol 2001; 66: 83-388.
18. Chen HC, Hu WX, Liu QX, et al. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev 2008; 17: 251-258.
19. Rollinson S, Roddam P, Kane E, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis 2000; 21: 43-47.
20. Tsabouri S, Georgiou I, Katsaraki A, Bourantas KL. Glutathione sulfur transferase M1 and T1 genotypes in chronic lymphoblastic leukemia. Hematol J 2004; 5: 500-504.
21. Yuille M, Condie A, Hudson C, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 2002; 99: 4216-4218.
22. Sutton JF, Stacey M, Kearns WG, et al. Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes. Pediatr Blood Cancer 2004; 42: 122-126.
23. Taspinar M, Aydos SE, Comez O, et al. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia. Swiss Med Wkly 2008; 138: 12-17.
24. Basu T, Gale RE, Langabeer SE, Linch DC. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 1997; 347: 1450.
25. Atoyebi W, Kusec R, Fidler C, et al. Glutathione S-transferase gene deletions in myelodysplasia. Lancet 1997; 349: 1450-1451.
26. Preudhomme C, Nisse C, Hebbar M, et al. Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia 1997; 11: 1580-1582.
27. Zintzaras E. Glutathione S-transferase M1 and T1 genes and susceptibility to chronic myeloid leukemia: a meta-analysis. Genet Test Mol Biomarkers 2009; 13: 791-797.
28. Lemos MC, Cabrita FJ, Silva HA, et al. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999; 20: 1225-1229.
29. Hishida A, Terakura S, Emi N, et al. GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev 2005; 6: 251-255.
30. Lourenco GJ, Ortega MM, Nascimento H, et al. Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur J Haematol 2005; 75: 530-531.
31. Souza CL, Barbosa CG, Neto JP, et al. Polymorphisms in the glutathione S-transferase theta and mu genes and susceptibility to myeloid leukemia in Brazilian patients. Genet Mol Biol 2008; 31: 39-41.
32. Sambrook J, Russell D. Preparation and Analysis of Eukaryotic Genomic DNA. In Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 2001; 68-69.
33. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-191.
34. Mondal BC, Paria N, Majumdar S, et al. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev 2005; 14: 281-284.
35. Bajpai P, Tripathi AK, Agrawal D. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res 2007; 31: 1359-1363.
36. Voso MT, D'Alo F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002; 100: 2703-2707.
37. Macho A, Hirsch T, Marzo I, et al. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol 1997; 158: 4612-4619.
38. Yaris F, Dikici M, Akbulut T, Yaris E, Sabuncu H. Story of benzene and leukemia: epidemiologic approach of Muzaffer Aksoy. J Occup Health 2004; 46: 244-247.
39. Bjork J, Albin M, Welinder H, et al. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia? Occup Environ Med 2001; 58: 722-727.
40. Hayes RB, Songnian Y, Dosemeci M, Linet M. Benzene and lymphohematopoietic malignancies in humans. Am J Ind Med 2001; 40: 117-126.
41. Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health 2010; 9: 31.
42. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004; 43: 100-109.
43. Ye Z, Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer 2005; 41: 980-989.
44. Ada AO, Suzen SH, Iscan M. Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 2004; 151: 311-315.
45. Toruner GA, Akyerli C, Ucar A, et al. Polymorphisms of glutathione S-transferase genes (GSTM1, 0GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 2001; 75: 459-464.
46. Pinarbasi H, Silig Y, Cetinkaya O, Seyfikli Z, Pinarbasi E. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genet Cytogenet 2003; 146: 125-129.
47. Aktas D, Ozen H, Atsu N, et al. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer? Cancer Genet Cytogenet 2001; 125: 1-4.
48. Oke B, Akbas F, Aydin M, Berkkan H. GSTT1 null genotype frequency in a Turkish population. Arch Toxicol 1998; 72: 454-455.
49. Calikoglu M, Tamer L, Ates-Aras N, Karakas S, Ercan B. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population. Biochem Genet 2006; 44: 307-319.
50. Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004; 10: 2675-2680.
51. Hsieh LL, Liou SH, Chiu LL, Chen YH. Glutathione S-transferase (GST) M1 and GST T1 genotypes and hematopoietic effects of benzene exposure. Arch Toxicol 1999; 73: 80-82.